Key | % Net Assets |
---|---|
BP | 8.3% |
GlaxoSmithKline | 8.0% |
Schroder Inst UK Smaller Cos Fund Inc Units | 5.6% |
HSBC Holdings | 5.5% |
Other | 72.6% |
Name | % Net Assets |
---|---|
BP | 8.3% |
GlaxoSmithKline | 8.0% |
Schroder Inst UK Smaller Cos Fund Inc Units | 5.6% |
HSBC Holdings | 5.5% |
Shell Transport & Trading | 5.0% |
Vodafone Group | 4.9% |
BT Group | 2.7% |
AstraZeneca | 2.7% |
Lloyds TSB Group | 2.5% |
Aggregate Industries | 2.3% |
No asset data available.
Date | 08-Jun-2018 |
---|---|
Bid | 1,209.00p |
Offer | 1,211.00p |
Currency | GBP |
Change | 7.00p |
% | 0.58% |
YTD change | 1,210.00p |
YTD % | n/a |
Fund Inception | 03/03/1992 |
---|---|
Fund Manager | Humphrey Van Der Klugt |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 1.00% |
Annual Mang't | 0.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.36 |
You are here: research